Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-02-15
2011-02-15
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S263200, C514S263220, C540S580000, C544S268000, C546S113000, C548S453000
Reexamination Certificate
active
07888343
ABSTRACT:
The present invention involves substituted bicyclic 8-pyrrolidinoxanthines and their derivatives of formula I:wherein the various R groups are defined herein. The present invention also comprises pharmaceutical compositions comprising them as well as processes for the preparation of these compounds and methods for the treatment of metabolic disorders such as type-2 diabetes, insulin resistance, hyperglycemia, arteriosclerosis diseases and the like through the administration of said compositions.
REFERENCES:
patent: 3472861 (1969-10-01), Schulz et al.
patent: 7074798 (2006-07-01), Yoshikawa et al.
patent: 7235538 (2007-06-01), Kanstrup et al.
patent: 7495004 (2009-02-01), Boggs et al.
patent: 2004/0087587 (2004-05-01), Himmelsbach et al.
patent: 2007/0167468 (2007-07-01), Schoenafinger et al.
patent: 1338595 (2003-10-01), None
patent: WO 0063208 (2000-10-01), None
patent: WO 02/068420 (2002-09-01), None
Blandine Laferrere et al., Effects of bombesin, of a new bombesin agonist (BIM187) and a new antagonist (BIM189) on food intake in rats, in relation to cholecystokinin, European Journal of Pharmacology, (1992), vol. 215, pp. 23-28.
Corri Black, et al., Meglitinide analogues for type 2 diabetes meilitus , The Cochrane Review, (2007).
Renzo Cescato, et al., Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting, The Journal of Nuclear Medicine, 2008, vol. 49, No. 2, pp. 318-326.
Buning Christian
Defossa Elisabeth
Jaehne Gerhard
Schoenafinger Karl
Schwink Lothar
Berch Mark L
Sanofi-A Ventis Deutschland GmbH
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Substituted, bicyclic 8-pyrrolidinoxanthines, and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted, bicyclic 8-pyrrolidinoxanthines, and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted, bicyclic 8-pyrrolidinoxanthines, and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2638087